Monthly Archives: March 2013

India’s Supreme Court Rejects Novartis’s Claim Citing Responsibility toward the Developing World

On 1 April India’s supreme court rejected Novartis AG’s request to patent a new version of Gleevec, a cancer treatment drug, taking into account the “commitment to protect and promote public health considerations, not only of its own people but in many other parts of the world (particularly in the Developing Countries and the Least Developed Countries).” (para. 66). Continue reading